GlassScriptPhysician profile
Scott E Kurzrok
NPI 1073515375
$19,768.21
in general payments reported to CMS, 2019-2025
64 companies · $3,233 in 2025
The $3,233 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,045 · 2020: $2,101 · 2021: $2,751 · 2022: $2,576 · 2023: $3,061 · 2024: $3,000 · 2025: $3,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,294.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,564.70 | 2019-2025 | |
| Novo Nordisk INC | $1,489.81 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,403.66 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $1,271.04 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,217.01 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $1,156.28 | 2021-2025 | |
| Lilly USA, LLC | $1,117.75 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Novartis Pharmaceuticals Corporation | $647.85 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $641.45 | 2019-2025 | Belsomra, Lagevrio |
| Astellas Pharma US INC | $596.10 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $585.31 | 2019-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $540.35 | 2019-2025 | Jardiance, Synjardy |
| Teva Pharmaceuticals USA, INC. | $529.03 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Kowa Pharmaceuticals America, INC. | $514.69 | 2019-2025 | Seglentis, Zoryve, Livalo |
| Amarin Pharma, INC. | $506.37 | 2019-2022 |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $280.44 | 2019-2020 | |
| Almatica Pharma LLC | $270.97 | 2023-2025 | Loreev Xr |
| Idorsia Pharmaceuticals US INC | $259.33 | 2023-2024 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $254.26 | 2019-2025 | Xifaxan |
| Corium, LLC | $250.78 | 2022-2024 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $224.61 | 2020-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $223.96 | 2019-2024 | Trintellix |
| Abbott Laboratories | $212.63 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3, Proclaim |
| Sanofi-Aventis U.S. LLC | $128.83 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $126.84 | 2020-2024 | Xarelto |
| Boston Scientific Corporation | $122.13 | 2019-2025 | Watchman Access System, Bodyguardian, Ams 700 |
| Exact Sciences Corporation | $108.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $106.19 | 2020-2021 | |
| Forte Bio-Pharma LLC | $95.95 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $95.14 | 2023-2025 | Caplyta |
| Biohaven Pharmaceuticals, INC. | $81.92 | 2021 | |
| Mylan Specialty L.P. | $81.73 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $76.11 | 2019-2021 | |
| Kvk-Tech, INC. | $72.98 | 2025 | |
| Axsome Therapeutics, INC. | $72.67 | 2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $68.99 | 2022-2024 | Eliquis |
| Biohaven Pharmaceutical Holding Company LTD. | $61.69 | 2022 | |
| Vanda Pharmaceuticals INC. | $60.38 | 2024-2025 | Fanapt |
| Dexcom, INC. | $58.53 | 2023-2025 | Dexcom G6 Transmitter |
| Collegium Pharmaceutical, INC. | $49.26 | 2020-2025 | Belbuca |
| Arbor Pharmaceuticals, INC. | $40.47 | 2019-2021 | |
| Shield Therapeutics INC | $39.81 | 2024 | |
| Scilex Pharmaceuticals INC. | $35.14 | 2019 | |
| Circassia INC. | $33.34 | 2019 | |
| Scpharmaceuticals INC. | $31.71 | 2025 | |
| Phathom Pharmaceuticals, INC. | $28.30 | 2023-2024 | Voquezna |
| Ferring Pharmaceuticals INC. | $27.37 | 2022-2023 | Rebyota |
| Horizon Therapeutics Plc | $24.57 | 2021 | |
| Stryker Corporation | $23.79 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sun Pharmaceutical Industries INC. | $21.80 | 2021 | |
| Lundbeck LLC | $21.70 | 2025 | Rexulti |
| Inari Medical, INC. | $21.53 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Hologic Sales and Service, LLC | $21.50 | 2025 | Aptima |
| Aimmune Therapeutics, INC. | $18.96 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $18.02 | 2021 | |
| Linus Health, INC. | $16.89 | 2024 | Core Cognitive Evaluation |
| Hikma Pharmaceuticals USA | $16.23 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $15.74 | 2025 | |
| Inspire Medical Systems, INC. | $15.62 | 2025 | Inspire |
| Intra-Sana Laboratories | $15.49 | 2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Philips North America LLC | $14.93 | 2019 | |
| Vistapharm, INC. | $14.85 | 2021 | |
| Avanir Pharmaceuticals, INC. | $13.24 | 2019 | |
| Metuchen Pharmaceuticals | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Kurzrok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.